|
|
 |
|
Viewing report
|
|
 |
Withdrawal of Sitaxentan (Thelin) Creates Huge Unmet Need in the Pulmonary Arterial Hypertension (PAH) Market
GlobalData, Feb 2011, Pages: 5
Withdrawal of Sitaxentan (Thelin) Creates Huge Unmet Need in the Pulmonary Arterial Hypertension (PAH) Market
Summary
GlobalData’s report, “Withdrawal of Sitaxentan (Thelin) Creates Huge Unmet Need in the Pulmonary Arterial Hypertension (PAH) Market” provides key data, information on PAH Market.
Scope
- Data and information on noval therapy on PAH market
Reasons to buy
- Develop business strategies by understanding the trends and developments in PAH Market
|
 |
|
|